Why the study?
Vascular ageing measurements are emerging cardiovascular risk markers, but vascular ageing is not yet routinely assessed in clinical practice, requiring the development of assessment technologies.
Design
Expert roadmap
Vascular ageing technologies need prospective validation before clinical adoption; leaves open prioritized research directions for device development.
Vascular ageing (vascular ageing) is the deterioration of arterial structure and function which occurs naturally with age, and which can be accelerated with disease. Measurements of vascular ageing are emerging as markers of cardiovascular risk, with potential applications in disease diagnosis and prognosis, and for guiding treatments. However, vascular ageing is not yet routinely assessed in clinical practice. A key step towards this is the development of technologies to assess vascular ageing. In this Roadmap, experts discuss several aspects of this process, including: measurement technologies; the development pipeline; clinical applications; and future research directions. The Roadmap summarises the state of the art, outlines the major challenges to overcome, and identifies potential future research directions to address these challenges.
No takes yet. Share an insight, caveat, or question.
Zanelli et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: